Since SIRT1 promotes DSBR by deacetylating Ku70 in CML cells, the NHEJ pathway may be impaired through inhibition of SIRT1, which increases Ku70 acetylation [76]. Here, XRCC6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.